CFTR and cystic fibrosis: Combined with the issue that non-White individuals largely possess CFTR variants excluded from modulator labels [10], [14], [16], [21], [25], [74], [75], [76], [77], either due to confirmation of unresponsiveness or absence of testing, these CF communities experience distinctly elevated risk.